MENU
+Compare
NKTX
Stock ticker: NASDAQ
AS OF
Aug 25 closing price
Price
$2.20
Change
-$0.17 (-7.17%)
Capitalization
156.25M

NKTX Nkarta Forecast, Technical & Fundamental Analysis

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NKTX with price predictions
Aug 25, 2025

NKTX in +4.87% Uptrend, rising for three consecutive days on August 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NKTX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on NKTX as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NKTX just turned positive on August 15, 2025. Looking at past instances where NKTX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 139 cases where NKTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NKTX moved out of overbought territory on July 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where NKTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NKTX broke above its upper Bollinger Band on August 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.437) is normal, around the industry mean (19.083). P/E Ratio (0.000) is within average values for comparable stocks, (54.504). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.646). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (304.949).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NKTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NKTX is expected to report earnings to rise 9.03% to -33 cents per share on November 05

Nkarta NKTX Stock Earnings Reports
Q3'25
Est.
$-0.34
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.02
The last earnings report on August 12 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 668.99K shares outstanding, the current market capitalization sits at 156.25M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUTH0.100.02
+25.31%
Standard Dental Labs Inc.
AGGZF30.220.50
+1.68%
AG Growth International Inc.
ASBFY31.49-0.26
-0.80%
Associated British Foods plc
DBGI9.63-1.06
-9.96%
Digital Brands Group Inc
TLPPF11.01-1.39
-11.21%
Telix Pharmaceutical Ltd.

NKTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-7.17%
BEAM - NKTX
49%
Loosely correlated
-1.20%
FATE - NKTX
49%
Loosely correlated
-5.22%
CRBU - NKTX
48%
Loosely correlated
+1.62%
SYRE - NKTX
47%
Loosely correlated
-4.60%
IMNM - NKTX
44%
Loosely correlated
-3.69%
More